La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Norepinephrine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nonlinear Dynamics < Norepinephrine < Norepinephrine Plasma Membrane Transport Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000529 (2014) Safa Bouabid [Maroc] ; Claire Delaville [France] ; Philippe De Deurwaerdère [France] ; Nouria Lakhdar-Ghazal [Maroc] ; Abdelhamid Benazzouz [France]Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.
000833 (2012) M. Sabbar [France] ; C. Delaville ; P. De Deurwaerdère ; A. Benazzouz ; N. Lakhdar-GhazalLead intoxication induces noradrenaline depletion, motor nonmotor disabilities, and changes in the firing pattern of subthalamic nucleus neurons.
000859 (2012) C. Delaville [France] ; S. Navailles ; A. BenazzouzEffects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
000A29 (2010) David Devos [France] ; L. Defebvre ; R. BordetDopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
000E43 (2006) Jean-Pierre Wolf [France] ; Malika Bouhaddi ; Francis Louisy ; Andrei Mikehiev ; Laurent Mourot ; Sylvie Cappelle ; Fabrice Vuillier ; Pierre Andre ; Lucien Rumbach ; Jacques RegnardSide-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.
000F02 (2005) Philippe Remy [France] ; Miroslava Doder ; Andrew Lees ; Nora Turjanski ; David BrooksDepression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
001132 (2002) Christine Brefel-Courbon [France][Parkinson disease and the noradrenaline system].
001135 (2002) Anne-Marie Bonnet [France][Alpha-2 adrenergic receptors and Parkinson's disease].
001179 (2002) L. Cathala [France] ; A. Guyon ; D. Eugene ; D. Paupardin-TritschAlpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra.
001397 (1999) O. Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
001521 (1996) M E Llau [France] ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L MontastrucA study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001606 (1995) H. Lefebvre [France] ; C. Noblet ; N. Moore ; L M WolfPseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
001607 (1995) R M Marié [France] ; L. Barré ; P. Rioux ; P. Allain ; B. Lechevalier ; J C BaronPET imaging of neocortical monoaminergic terminals in Parkinson's disease.
001638 (1994) M. Galinier [France] ; J M Senard ; P. Valet ; J P Doazan ; G. Durrieu ; M A Tran ; J L Monstastruc ; J P BounhoureRelationship between arterial blood pressure disturbances and alpha adrenoceptor density.
001686 (1993) M. Briley [France]Noradrenergic mechanisms in Parkinson's disease.
001742 (1991) P. Gaspar [France] ; C. Duyckaerts ; C. Alvarez ; F. Javoy-Agid ; B. BergerAlterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease.
001756 (1991) G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L MontastrucEffects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
001770 (1990) G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. MontastrucBeta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
001771 (1990) J M Senard [France] ; P. Valet ; G. Durrieu ; M. Berlan ; M A Tran ; J L Montastruc ; A. Rascol ; P. MontastrucAdrenergic supersensitivity in parkinsonians with orthostatic hypotension.
001782 (1990) G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L MontastrucBlood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Norepinephrine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Norepinephrine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Norepinephrine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024